Literature DB >> 31111347

Improvements in cardiac function detected using echocardiography in patients with hereditary haemochromatosis.

Danielle Byrne1,2, John Patrick Walsh3, Caroline Daly4,5, Susan McKiernan6, Suzanne Norris6, Ross T Murphy5, Gerard King5.   

Abstract

BACKGROUND: Hereditary haemochromatosis is often not diagnosed until adulthood. Iron overload cardiomyopathy initially results in diastolic dysfunction and can result in arrhythmias and irreversible cardiac failure if untreated. The aim of this study was to investigate whether patients with newly diagnosed hereditary haemochromatosis without signs of heart failure exhibit subclinical alterations of cardiac function and to determine if cardiac function improved after 1 year of venesection.
METHODS: Baseline echocardiography was performed on 25 patients with newly diagnosed hereditary haemochromatosis with elevated serum ferritin levels. The test was repeated after 1 year of treatment with venesection. Tissue Doppler imaging (TDI) and deformation (strain) imaging using speckle tracking were performed. Left atrial force was measured according to the Newtonian principle, in which force (dynes) = mass × acceleration. Left atrial force was calculated by the Manning method expressed as ρ × 0.53 × mitral annular orifice area × (peak A velocity)2.
RESULTS: Radial strain showed a significant improvement after 1 year of venesection (increase from 38.8 to 52.6). The LAF showed a significant decrease after 1 year of venesection (median decrease = 0.6 (IQR 0, 1.60), p = 0.0004). Iso-volumetric relaxation time (IVRT) decreased significantly in patients after 1 year of venesection (decrease from 107.4 ± 16.2 to 97.68 ± 15.4 ms, p (0.0187)).
CONCLUSION: Among all measurements, radial strain, IVRT and left atrial force were shown to significantly improve following a 1-year course of venesection, suggesting that these parameters could be used to identify subclinical cardiac dysfunction in patients with iron overload secondary to hereditary haemochromatosis and to guide intensification of venesection therapy.

Entities:  

Keywords:  Echocardiography/methods; Haemochromatosis/complications; Heart failure/aetiology; Iron overload cardiomyopathy

Mesh:

Year:  2019        PMID: 31111347     DOI: 10.1007/s11845-019-02032-5

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  31 in total

Review 1.  Iron overload cardiomyopathy in clinical practice.

Authors:  Dimitrios T Kremastinos; Dimitrios Farmakis
Journal:  Circulation       Date:  2011-11-15       Impact factor: 29.690

Review 2.  Recommendations for the evaluation of left ventricular diastolic function by echocardiography.

Authors:  Sherif F Nagueh; Christopher P Appleton; Thierry C Gillebert; Paolo N Marino; Jae K Oh; Otto A Smiseth; Alan D Waggoner; Frank A Flachskampf; Patricia A Pellikka; Arturo Evangelista
Journal:  J Am Soc Echocardiogr       Date:  2009-02       Impact factor: 5.251

Review 3.  Diagnosis and management of hereditary haemochromatosis.

Authors:  M A van Bokhoven; C Th B M van Deursen; D W Swinkels
Journal:  BMJ       Date:  2011-01-19

4.  On T2* magnetic resonance and cardiac iron.

Authors:  John-Paul Carpenter; Taigang He; Paul Kirk; Michael Roughton; Lisa J Anderson; Sofia V de Noronha; Mary N Sheppard; John B Porter; J Malcolm Walker; John C Wood; Renzo Galanello; Gianluca Forni; Gualtiero Catani; Gildo Matta; Suthat Fucharoen; Adam Fleming; Michael J House; Greg Black; David N Firmin; Timothy G St Pierre; Dudley J Pennell
Journal:  Circulation       Date:  2011-03-28       Impact factor: 29.690

5.  Iron in the heart. Etiology and clinical significance.

Authors:  L M Buja; W C Roberts
Journal:  Am J Med       Date:  1971-08       Impact factor: 4.965

Review 6.  Hereditary hemochromatosis.

Authors:  Brian K Crownover; Carlton J Covey
Journal:  Am Fam Physician       Date:  2013-02-01       Impact factor: 3.292

Review 7.  Iron overload cardiomyopathies: new insights into an old disease.

Authors:  P Liu; N Olivieri
Journal:  Cardiovasc Drugs Ther       Date:  1994-02       Impact factor: 3.727

8.  Iron overload in polytransfused patients without heart failure is associated with subclinical alterations of systolic left ventricular function using cardiovascular magnetic resonance tagging.

Authors:  Stéphanie Seldrum; Sophie Pierard; Stéphane Moniotte; Christiane Vermeylen; David Vancraeynest; Agnès Pasquet; Jean-Louis Vanoverschelde; Bernhard L Gerber
Journal:  J Cardiovasc Magn Reson       Date:  2011-04-26       Impact factor: 5.364

9.  Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases.

Authors:  Bruce R Bacon; Paul C Adams; Kris V Kowdley; Lawrie W Powell; Anthony S Tavill
Journal:  Hepatology       Date:  2011-07       Impact factor: 17.425

10.  On myocardial siderosis and left ventricular dysfunction in hemochromatosis.

Authors:  John-Paul Carpenter; Agata E Grasso; John B Porter; Farrukh Shah; James Dooley; Dudley J Pennell
Journal:  J Cardiovasc Magn Reson       Date:  2013-03-19       Impact factor: 5.364

View more
  2 in total

1.  The role of speckle tracking echocardiography in monitoring cardiac function in patients with hereditary hemochromatosis.

Authors:  Danilowicz-Szymanowicz Ludmila; Katarzyna Sikorska; Grzegorz Raczak
Journal:  Ir J Med Sci       Date:  2019-11-05       Impact factor: 1.568

Review 2.  The Importance of Multimodality Imaging in the Diagnosis and Management of Patients with Infiltrative Cardiomyopathies: An Update.

Authors:  Radu Sascău; Larisa Anghel; Alexandra Clement; Mădălina Bostan; Rodica Radu; Cristian Stătescu
Journal:  Diagnostics (Basel)       Date:  2021-02-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.